NEW YORK -- The world market for products to treat skin ulcers will grow at nearly 10 percent per year to surpass $5 billion by 2009, according to a new report released today from Kalorama Information. The increasing elderly population, the availability of new therapeutic techniques, and the recent cost-driven focus on wound care management and prevention are driving the growth.
The new study, Wound Care Markets, Volume I: Skin Ulcers, found that certain segments of the market to treat decubitus, neuropathic, arterial and venous ulcers are mature, such as anti-infectives, most skin ulcer management products, and pressure relief devices. However, other segments, such as biological dressings, are still in the infant stages and wide open for development and tremendous growth.
"The opportunities in skin ulcer treatment are very exciting, but the competition is fierce," notes Mary Anne Crandall, the author of the report. "Manufacturers must keep abreast of emerging products, the latest reimbursement changes, and constantly shifting physician usage patterns."
The study examines six broad categories of products-anti-infectives, skin ulcer management products, moist dressings, biological dressings, pressure relief devices, and other miscellaneous treatments-and more than 14 subcategories, including compression dressings and bandages, wound cleaners, debridement products, alginates, films, foams, hydrocolloids, hydrogels, artificial skin products, collagen products, and growth factors.
In addition to a thorough analysis of market size and growth rates through 2009 for each segment and subsegment, the study details competitive market share in each segment and provides a thorough understanding of the clinical and reimbursement environment in which these wound care manufacturers operate.
Source: Kalorama Information
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.